American Medical Technologies Inc. (ADLI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2007 | -926.89 Thousand USD | 32.93% |
| 2006 | -1.38 Million USD | 10.54% |
| 2005 | -1.54 Million USD | -5340.79% |
| 2004 | 29.47 Thousand USD | -45.08% |
| 2003 | 53.67 Thousand USD | 100.76% |
| 2002 | -7.04 Million USD | -77.05% |
| 2001 | -3.97 Million USD | 78.38% |
| 2000 | -18.4 Million USD | -4799.49% |
| 1999 | 391.6 Thousand USD | -95.57% |
| 1998 | 8.84 Million USD | 144.34% |
| 1997 | 3.62 Million USD | -35.66% |
| 1996 | 5.62 Million USD | 532.98% |
| 1995 | -1.3 Million USD | 69.05% |
| 1994 | -4.2 Million USD | 38.24% |
| 1993 | -6.8 Million USD | 54.05% |
| 1992 | -14.8 Million USD | -14900.0% |
| 1991 | 100 Thousand USD | -85.71% |
| 1990 | 700 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2008 Q3 | -117.16 Thousand USD | -169.16% |
| 2008 Q2 | 169.39 Thousand USD | 3593.81% |
| 2008 Q1 | 4586.00 USD | -96.66% |
| 2007 Q2 | -54.94 Thousand USD | 92.07% |
| 2007 Q1 | -692.71 Thousand USD | -11653.0% |
| 2007 FY | -926.89 Thousand USD | 32.93% |
| 2007 Q4 | 137.18 Thousand USD | 143.36% |
| 2007 Q3 | -316.41 Thousand USD | -475.84% |
| 2006 Q3 | -176.34 Thousand USD | 35.95% |
| 2006 FY | -1.38 Million USD | 10.54% |
| 2006 Q1 | -936.31 Thousand USD | -39.65% |
| 2006 Q2 | -275.33 Thousand USD | 70.59% |
| 2006 Q4 | 5996.00 USD | 103.4% |
| 2005 FY | -1.54 Million USD | -5340.79% |
| 2005 Q1 | -288.91 Thousand USD | 47.37% |
| 2005 Q2 | -265.15 Thousand USD | 8.22% |
| 2005 Q3 | -320.21 Thousand USD | -20.77% |
| 2005 Q4 | -670.48 Thousand USD | -109.39% |
| 2004 Q3 | -161.89 Thousand USD | 53.35% |
| 2004 Q2 | -347.01 Thousand USD | -131.91% |
| 2004 Q4 | -548.93 Thousand USD | -239.06% |
| 2004 FY | 29.47 Thousand USD | -45.08% |
| 2004 Q1 | 1.08 Million USD | 139.62% |
| 2003 Q3 | -20.95 Thousand USD | -100.62% |
| 2003 FY | 53.67 Thousand USD | 100.76% |
| 2003 Q1 | -567.05 Thousand USD | 79.72% |
| 2003 Q2 | 3.38 Million USD | 697.12% |
| 2003 Q4 | -2.74 Million USD | -12999.04% |
| 2002 Q2 | -2.6 Million USD | -229.84% |
| 2002 Q3 | -857.67 Thousand USD | 67.03% |
| 2002 Q4 | -2.79 Million USD | -225.93% |
| 2002 FY | -7.04 Million USD | -77.05% |
| 2002 Q1 | -788.74 Thousand USD | 61.84% |
| 2001 Q1 | 104.83 Thousand USD | 100.6% |
| 2001 Q3 | -1.2 Million USD | -49.9% |
| 2001 FY | -3.97 Million USD | 78.38% |
| 2001 Q2 | -806.69 Thousand USD | -869.51% |
| 2001 Q4 | -2.06 Million USD | -70.95% |
| 2000 Q3 | -247.9 Thousand USD | -279.49% |
| 2000 FY | -18.4 Million USD | -4799.49% |
| 2000 Q4 | -17.54 Million USD | -6978.31% |
| 2000 Q2 | 138.11 Thousand USD | 118.51% |
| 2000 Q1 | -745.98 Thousand USD | -370.33% |
| 1999 Q4 | 275.94 Thousand USD | 653.13% |
| 1999 Q1 | 128.67 Thousand USD | -98.01% |
| 1999 Q2 | 466.55 Thousand USD | 262.58% |
| 1999 Q3 | -49.88 Thousand USD | -110.69% |
| 1999 FY | 391.6 Thousand USD | -95.57% |
| 1998 Q4 | 6.45 Million USD | 1074.19% |
| 1998 FY | 8.84 Million USD | 144.34% |
| 1998 Q2 | 1 Million USD | 19.24% |
| 1998 Q3 | 549.85 Thousand USD | -45.15% |
| 1998 Q1 | 840.66 Thousand USD | -28.44% |
| 1997 Q1 | 886.27 Thousand USD | -76.31% |
| 1997 FY | 3.62 Million USD | -35.66% |
| 1997 Q4 | 1.17 Million USD | 648.16% |
| 1997 Q3 | 157.01 Thousand USD | -88.81% |
| 1997 Q2 | 1.4 Million USD | 58.39% |
| 1996 Q4 | 3.74 Million USD | 399.54% |
| 1996 FY | 5.62 Million USD | 532.98% |
| 1996 Q3 | 748.99 Thousand USD | 8.56% |
| 1996 Q1 | 400 Thousand USD | 157.14% |
| 1996 Q2 | 689.94 Thousand USD | 72.49% |
| 1995 Q4 | -700 Thousand USD | 30.0% |
| 1995 FY | -1.3 Million USD | 69.05% |
| 1995 Q3 | -1 Million USD | -600.0% |
| 1995 Q2 | 200 Thousand USD | 0.0% |
| 1995 Q1 | 200 Thousand USD | 111.76% |
| 1994 FY | -4.2 Million USD | 38.24% |
| 1994 Q2 | -400 Thousand USD | 0.0% |
| 1994 Q4 | -1.7 Million USD | 0.0% |
| 1994 Q3 | -1.7 Million USD | -325.0% |
| 1994 Q1 | -400 Thousand USD | 88.57% |
| 1993 Q2 | -1.1 Million USD | -120.0% |
| 1993 Q1 | -500 Thousand USD | 90.74% |
| 1993 FY | -6.8 Million USD | 54.05% |
| 1993 Q4 | -3.5 Million USD | -105.88% |
| 1993 Q3 | -1.7 Million USD | -54.55% |
| 1992 FY | -14.8 Million USD | -14900.0% |
| 1992 Q2 | -3.1 Million USD | -29.17% |
| 1992 Q3 | -3.9 Million USD | -25.81% |
| 1992 Q1 | -2.4 Million USD | 0.0% |
| 1992 Q4 | -5.4 Million USD | -38.46% |
| 1991 Q3 | 800 Thousand USD | -11.11% |
| 1991 Q4 | -2.4 Million USD | -400.0% |
| 1991 Q1 | 800 Thousand USD | 0.0% |
| 1991 Q2 | 900 Thousand USD | 12.5% |
| 1991 FY | 100 Thousand USD | -85.71% |
| 1990 Q4 | - USD | 0.0% |
| 1990 FY | 700 Thousand USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Ansell Limited | 76.5 Million USD | 101.212% |
| Ansell Limited | 76.5 Million USD | 101.212% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 103.817% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 43.144% |
| Psykey, Inc. | -1.32 Million USD | 29.99% |
| ConvaTec Group Plc | 130.3 Million USD | 100.711% |
| ConvaTec Group Plc | 130.3 Million USD | 100.711% |
| Encision Inc. | -691.78 Thousand USD | -33.986% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -553.611% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -295.49% |
| Innovative MedTech Inc. | -7.93 Million USD | 88.325% |
| LifePoint, Inc. | -15.23 Million USD | 93.915% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 86.391% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | -95.547% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | -237.732% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | -101.925% |
| SmileDirectClub, Inc. | -86.4 Million USD | 98.927% |
| Sector 10, Inc. | 7036.00 USD | 13273.579% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.046% |
| SheerVision, Inc. | -71.37 Thousand USD | -1198.606% |
| United Health Products, Inc. | -2.62 Million USD | 64.666% |
| Vasamed, Inc. | -4.88 Million USD | 81.038% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 61.193% |
| Yubo International Biotech Limited | -1.2 Million USD | 23.064% |